A preclinical drug discovery company designing RNA-targeting small molecules, pairing proprietary RNA-binding datasets with generative chemistry.
Serna Bio / CompChem Solutions / University of Michigan
Released May 12, 2026
Generative chemistry ensemble fine-tuned on 2.4M RNA-small molecule binding measurements, designing analogues around a seed compound.